Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism

NCT02081300 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Male Hypogonadism

Interventions

DRUG: Oral testosterone undecanoate, LPCN 1021
DRUG: Topical testosterone gel 1.62 %

Sponsor

Lipocine Inc.

Collaborators

[object Object]
[object Object]